发明名称 STABLE FREEZE-DRY HERPES VIRUS LIVE VACCINE
摘要 <p>PURPOSE: To obtain a herpes virus live vaccine by lyophilizing the herpes virus live vaccine with a gas injection until the vaccine attains a specific moisture content to increase the preservation stability thereof. CONSTITUTION: This stable lyophilized herpes virus live vaccine, capable of preferably forming a mixed vaccine with four vaccines by mixing the vaccine with a varicella or a measles vaccine, a mumps vaccine and a rubella vaccine, and containing each of the vaccines in amounts effective for a person immunized with each of the vaccines, is obtained by a gas injection lyophilization by using a lyophilizing process preferably containing a first cycle with a gas injection and a second cycle, for approx. 7-11hr total time of both cycles to contain approx. 0.5-8%, preferably approx. 0.5-2%, approx. 2-5% or approx. 5-8% (as effective subset) moisture content to increase the preservation stability of the above vaccine and enabling the preservation thereof not at (-)20 deg.C (freezer) but at 5 deg.C (refrigerator).</p>
申请公布号 JPS646220(A) 申请公布日期 1989.01.10
申请号 JP19880109811 申请日期 1988.05.02
申请人 MERCK & CO INC 发明人 UIRIAMU JIEE MAKUAREE;HENRII ZETSUTO MAAKUSU;ROBAATO ZETSUTO MAIGETSUTAA
分类号 A61K39/165;A61K39/20;A61K39/245;A61K39/295;A61P31/12;A61P31/22 主分类号 A61K39/165
代理机构 代理人
主权项
地址